<?xml version="1.0" ?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:media="http://search.yahoo.com/mrss/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:seo="http://purl.org/seo/elements/1.0/" version="2.0">
	<channel>
		<title>TMX Newsfile Healthcare and Hospitals News Releases</title>
		<link>https://feeds.newsfilecorp.com/industry/health-care-hospitals</link>
		<description>Last 10 Healthcare and Hospitals news releases from TMX Newsfile. Contact us for a custom full-bodied RSS feed complete with exchange and ticker data.</description>
		<language>en</language>
		<copyright>CopyRight (c) 2026, Newsfile Corp. All Rights Reserved.</copyright>
		<managingEditor>office@newsfilecorp.com (Newsfile Corp.)</managingEditor>
		<webMaster>office@newsfilecorp.com (Newsfile Corp.)</webMaster>
		<lastBuildDate>Fri, 23 Oct 2026 09:58:55 -0400</lastBuildDate>
		<image>
			<url>https://www.newsfilecorp.com/images/tmx-newsfile-wire-logo.png</url>
			<title>TMX Newsfile Healthcare and Hospitals News Releases</title>
			<link>https://feeds.newsfilecorp.com/industry/health-care-hospitals</link>
		</image>
		<atom:link rel="self" type="application/rss+xml" href="https://feeds.newsfilecorp.com/industry/health-care-hospitals"/>
		<item xml:lang="en">
			<title>Global Hemp Group Appoints Mickey Goldstein as Chief Financial Officer, Appoints Davidson &amp; Company as Auditor</title>
			<link>https://www.newsfilecorp.com/release/320599/Global-Hemp-Group-Appoints-Mickey-Goldstein-as-Chief-Financial-Officer-Appoints-Davidson-Company-as-Auditor</link>
			<description>&lt;img src="https://api.newsfilecorp.com/newsinfo/320599/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;Vancouver, British Columbia--(Newsfile Corp. - October 23, 2026) - Global Hemp Group Inc. (CSE: GHG) (FSE: GHG0) (OTC PINK: GBHPF) ("GHG" or the "Company") is pleased to announce the appointment of Mickey Goldstein, CPA, CA, as Chief Financial Officer, effective immediately. Ms. Goldstein succeeds Christopher Cherry.Ms. Goldstein is Director, Accounting Advisory at Crowe MacKay LLP, where she provides strategic financial and advisory services to private and public companies across North America....</description>
			<pubDate>Fri, 23 Oct 2026 09:59:00 -0400</pubDate>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/320599/Global-Hemp-Group-Appoints-Mickey-Goldstein-as-Chief-Financial-Officer-Appoints-Davidson-Company-as-Auditor</guid>
		</item>
		<item xml:lang="en">
			<title>Aurora Spine Announces Publication of REFINE Study's 12-Month Results in the International Journal of Spine Surgery</title>
			<link>https://www.newsfilecorp.com/release/320514/Aurora-Spine-Announces-Publication-of-REFINE-Studys-12Month-Results-in-the-International-Journal-of-Spine-Surgery</link>
			<description>&lt;img src="https://api.newsfilecorp.com/newsinfo/320514/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;Carlsbad, California--(Newsfile Corp. - October 22, 2026) - Aurora Spine Corporation (TSXV: ASG) (OTCQB: ASAPF) ("Aurora Spine" or the "Company"), a developer and manufacturer of minimally invasive spinal implants and interventional pain management technologies, today announced the publication of the REFINE study's 12-month results in the International Journal of Spine Surgery.Published online on October 9, 2026, the article reports on a prospective, observational, open-label, nonrandomized,...</description>
			<pubDate>Thu, 22 Oct 2026 17:56:00 -0400</pubDate>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/320514/Aurora-Spine-Announces-Publication-of-REFINE-Studys-12Month-Results-in-the-International-Journal-of-Spine-Surgery</guid>
			<atom:subtitle>Peer-reviewed publication adds prospective, multicenter clinical evidence for the ZIP MIS Interlaminar Fusion System</atom:subtitle>
		</item>
		<item xml:lang="en">
			<title>Envoy Medical Announces Reverse Stock Split</title>
			<link>https://www.newsfilecorp.com/release/320270/Envoy-Medical-Announces-Reverse-Stock-Split</link>
			<description>&lt;img src="https://api.newsfilecorp.com/newsinfo/320270/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;White Bear Lake, Minnesota--(Newsfile Corp. - October 22, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health and neuroprosthetics company pioneering fully implanted hearing solutions, today announced that it will implement a 1-for-10 reverse stock split of its outstanding shares of Class A common stock ("Common Stock"), effective  at 12:01 a.m. Eastern Time on October 26, 2026 (the "Reverse Split"). The Company's Common Stock will continue to trade on...</description>
			<pubDate>Thu, 22 Oct 2026 08:30:00 -0400</pubDate>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/320270/Envoy-Medical-Announces-Reverse-Stock-Split</guid>
		</item>
		<item xml:lang="en">
			<title>TelyRx to Host Third Quarter 2026 Financial Results Conference Call on Friday, November 6, 2026 at 8:30 am ET</title>
			<link>https://www.newsfilecorp.com/release/320240/TelyRx-to-Host-Third-Quarter-2026-Financial-Results-Conference-Call-on-Friday-November-6-2026-at-830-am-ET</link>
			<description>&lt;img src="https://api.newsfilecorp.com/newsinfo/320240/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;Clearwater, Florida--(Newsfile Corp. - October 22, 2026) - TelyRx Holdings Inc. (TSX: TELY) (OTCQX: TELYF) ("TelyRx" or the "Company"), a vertically integrated, technology-enabled healthcare and pharmacy services company, today announced it will host a conference call and webcast to discuss its third quarter 2026 financial results on Friday, November 6, 2026, at 8:30 a.m. Eastern Time (ET). The Company expects to report its third quarter 2026 financial results for the period ended September 30,...</description>
			<pubDate>Thu, 22 Oct 2026 07:00:00 -0400</pubDate>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/320240/TelyRx-to-Host-Third-Quarter-2026-Financial-Results-Conference-Call-on-Friday-November-6-2026-at-830-am-ET</guid>
		</item>
		<item xml:lang="en">
			<title>CareRx Corporation to Host Third Quarter 2026 Financial Results Conference Call on Thursday, November 5, 2026 at 8:30 a.m. ET</title>
			<link>https://www.newsfilecorp.com/release/320191/CareRx-Corporation-to-Host-Third-Quarter-2026-Financial-Results-Conference-Call-on-Thursday-November-5-2026-at-830-a.m.-ET</link>
			<description>&lt;img src="https://api.newsfilecorp.com/newsinfo/320191/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;Toronto, Ontario--(Newsfile Corp. - October 22, 2026) - CareRx Corporation  (TSX: CRRX) ("CareRx" or the "Company") today announced it will host a conference call to discuss its third quarter 2026 financial results on Thursday, November 5, 2026, at 8:30 a.m. Eastern Time (ET). The Company expects to report its third quarter 2026 financial results for the period ended September 30, 2026, after market close on Wednesday, November 4, 2026.Telephone Dial-In Access InformationTo dial direct and enter...</description>
			<pubDate>Thu, 22 Oct 2026 07:00:00 -0400</pubDate>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/320191/CareRx-Corporation-to-Host-Third-Quarter-2026-Financial-Results-Conference-Call-on-Thursday-November-5-2026-at-830-a.m.-ET</guid>
		</item>
		<item xml:lang="en">
			<title>The Untold Story of Rick Hansen's Man In Motion World Tour Comes to the Big Screen Across Canada in November</title>
			<link>https://www.newsfilecorp.com/release/320138/The-Untold-Story-of-Rick-Hansens-Man-In-Motion-World-Tour-Comes-to-the-Big-Screen-Across-Canada-in-November</link>
			<description>&lt;img src="https://api.newsfilecorp.com/newsinfo/320138/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;Richmond, British Columbia--(Newsfile Corp. - October 21, 2026) - Man In Motion: The Rick Hansen Story will be a special event release by Cineplex in selected theatres  across Canada on November 1 and 3. Tickets are now on sale. The theatrical release follows the film's world premiere at the Toronto International Film Festival (TIFF), where it received an honourable mention for the Best Canadian Feature Film Award, and its hometown premiere at the Vancouver International Film Festival (VIFF)....</description>
			<pubDate>Wed, 21 Oct 2026 10:20:00 -0400</pubDate>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/320138/The-Untold-Story-of-Rick-Hansens-Man-In-Motion-World-Tour-Comes-to-the-Big-Screen-Across-Canada-in-November</guid>
			<atom:subtitle>Tickets are now on sale for Man In Motion: The Rick Hansen Story at theatres from coast to coast - an intimate look behind the historic journey through never-before-seen footage and Rick Hansen's private audio diaries.</atom:subtitle>
		</item>
		<item xml:lang="en">
			<title>Envoy Medical Hits Six-Month Milestone, Marks Halfway Point in Final Stage of Data Collection, and Highlights Differentiated Device Design</title>
			<link>https://www.newsfilecorp.com/release/319914/Envoy-Medical-Hits-SixMonth-Milestone-Marks-Halfway-Point-in-Final-Stage-of-Data-Collection-and-Highlights-Differentiated-Device-Design</link>
			<description>&lt;img src="https://api.newsfilecorp.com/newsinfo/319914/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;Company Believes It Is the First to Reach This Milestone in a U.S. Pivotal Trial of a Fully Implanted Cochlear ImplantRemains on Track to Reach 12-Month Visit Milestone by Early Q2 2027 and Submit Final Clinical PMA Module by End of Q2 2027White Bear Lake, Minnesota--(Newsfile Corp. - October 20, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health and neuroprosthetics company pioneering fully implanted hearing solutions, today announced that it has...</description>
			<pubDate>Tue, 20 Oct 2026 08:30:00 -0400</pubDate>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/319914/Envoy-Medical-Hits-SixMonth-Milestone-Marks-Halfway-Point-in-Final-Stage-of-Data-Collection-and-Highlights-Differentiated-Device-Design</guid>
		</item>
		<item xml:lang="en">
			<title>Adia Med Sells 7% Economic Interest in Adia Labs to CEO Larry Powalisz for $350,000 in Cash</title>
			<link>https://www.newsfilecorp.com/release/319712/Adia-Med-Sells-7-Economic-Interest-in-Adia-Labs-to-CEO-Larry-Powalisz-for-350000-in-Cash</link>
			<description>&lt;img src="https://api.newsfilecorp.com/newsinfo/319712/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;Winter Park, Florida--(Newsfile Corp. - October 20, 2026) - Adia Med, Inc. (OTCQB: ADIA) today announced that its Chief Executive Officer, Larry Powalisz, purchased a 7% economic interest in Adia Labs LLC for $350,000 in cash. Under the completed Membership Interest Purchase Agreement, Powalisz purchased seven membership units at $50,000 per unit. The Company has filed a Current Report on Form 8-K relating to the transaction.Adia Med Sells 7% Economic Interest in Adia Labs to CEO Larry Powalisz...</description>
			<pubDate>Tue, 20 Oct 2026 08:00:00 -0400</pubDate>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/319712/Adia-Med-Sells-7-Economic-Interest-in-Adia-Labs-to-CEO-Larry-Powalisz-for-350000-in-Cash</guid>
		</item>
		<item xml:lang="en">
			<title>ALZAI Health Corp. Posted for Trading On The OTCQB Venture Market</title>
			<link>https://www.newsfilecorp.com/release/319944/ALZAI-Health-Corp.-Posted-for-Trading-On-The-OTCQB-Venture-Market</link>
			<description>&lt;img src="https://api.newsfilecorp.com/newsinfo/319944/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;Toronto, Ontario--(Newsfile Corp. - October 20, 2026) - ALZAI Health Corp. (TSXV: ALZI) (OTCQB: ALZIF) (FSE: H2F) ("ALZAI" or the "Company"), a healthcare technology company developing artificial intelligence-driven disease risk identification solutions, is pleased to announce that its common shares are now quoted for trading on the OTCQB Venture Market ("OTCQB") in the United States under the symbol ALZIF.The OTCQB Venture Market, operated by OTC Markets Group Inc., is a U.S. marketplace for...</description>
			<pubDate>Tue, 20 Oct 2026 07:00:00 -0400</pubDate>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/319944/ALZAI-Health-Corp.-Posted-for-Trading-On-The-OTCQB-Venture-Market</guid>
		</item>
		<item xml:lang="en">
			<title>FendX Announces Appointment of Daryl Rebeck to Board of Directors</title>
			<link>https://www.newsfilecorp.com/release/319892/FendX-Announces-Appointment-of-Daryl-Rebeck-to-Board-of-Directors</link>
			<description>&lt;img src="https://api.newsfilecorp.com/newsinfo/319892/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;Vancouver, British Columbia--(Newsfile Corp. - October 20, 2026) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D0) (the "Company" or "FendX"), a technology company developing surface-protection solutions to reduce the spread of harmful pathogens, is pleased to announce the appointment of Mr. Daryl Rebeck to the board of directors, effective October 19, 2026. Mr. Rebeck's appointment follows the resignation of Mr. Pierre Soulard.  Mr. Rebeck is a Canadian entrepreneur, capital...</description>
			<pubDate>Tue, 20 Oct 2026 07:00:00 -0400</pubDate>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/319892/FendX-Announces-Appointment-of-Daryl-Rebeck-to-Board-of-Directors</guid>
		</item>
	</channel>
</rss>
